Arena Pharmaceuticals Inc EV/Sales

Quel est le EV/Sales de Arena Pharmaceuticals Inc?

Le EV/Sales de Arena Pharmaceuticals Inc est 104,741.92

Quelle est la définition de EV/Sales?



Enterprise value to sales ratio compares a company’s total value to its sales.

ttm (trailing twelve months)

Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.

EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.

EV/Sales des entreprises dans Health Care secteur sur NASDAQ par rapport à Arena Pharmaceuticals Inc

Que fait Arena Pharmaceuticals Inc?

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas

Entreprises avec ev/sales similaire à Arena Pharmaceuticals Inc